Cargando…
Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways
Objective: Both previous and recent literature showed long non-coding RNAs (lncRNAs) were crucial participants in multiple myeloma (MM) evolution. However, the dynamic regulation and mechanism of lncRNAs in MM progression was not fully understood. This study will explore the expression and effects o...
Autores principales: | Shen, Xianjuan, Shen, Pei, Yang, Qian, Yin, Qingqing, Wang, Feng, Cong, Hui, Wang, Xudong, Ju, Shaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856901/ https://www.ncbi.nlm.nih.gov/pubmed/31777580 http://dx.doi.org/10.7150/jca.35098 |
Ejemplares similares
-
PCAT‐1 promotes cell growth by sponging miR‐129 via MAP3K7/NF‐κB pathway in multiple myeloma
por: Shen, Xianjuan, et al.
Publicado: (2020) -
Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis
por: Yin, Qingqing, et al.
Publicado: (2018) -
The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma
por: Zhu, Bingying, et al.
Publicado: (2018) -
LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
por: Pan, Yafang, et al.
Publicado: (2019) -
Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)